Objective:To evaluate the value of two interferon-γ releasing assays(IGRA) in differential diagnosis of intestinal tubercu-losis(ITB) and Crohn’s disease(CD). Methods:Datebases of Embase,PubMed,EBM Reviews,CNKI,WanFang were searched for evaluating the value of IGRA in differential diagnosis of ITB and CD. The Meta-Disc was used to calculate the pooled sensitivity,specificity and 95% confidence interval(95%CI). Summary receiver operating characteristic curve(SROC),area under curve(AUC) and Q* were used to evaluate the efficiency of the two methods. Results:Totally 12 articles were included,including 854 patients(ITB 367,CD 487). The pooled sensitivity and specificity for T-SPOT TB were 0.89(95%CI=0.84 to 0.93) and 0.85(95%CI=0.81 to 0.89). The pooled sensitivity and specificity for Quantiferon-TB were 0.72(95%CI=0.64 to 0.79) and 0.92(95%CI=0.86 to 0.96). The AUC of SROC for the two methods were 0.9450 and 0.9110,and the Q* were 0.883 9 and 0.843 2. There was no statistically difference between the two methods(P=0.164). Conclusion:T-SPOT.TB and Quantiferon-TB are both effective ways for the differ-ential diagnosis of ITB and CD. But there was no statistically difference between the two methods.